Physician profile
Randall E Halley
NPI 1245232693
$17,926.80
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $17,431.83 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $159.30 | 2019 | |
| Supernus Pharmaceuticals, INC. | $115.12 | 2019 | |
| Scilex Pharmaceuticals INC. | $48.99 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.48 | 2019 | |
| Kaleo, INC. | $37.80 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.81 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $12.15 | 2019 | |
| Astellas Pharma US INC | $11.93 | 2019 | |
| Antares Pharma, INC. | $11.63 | 2019 | |
| Amgen INC. | $10.94 | 2019 | |
| Novartis Pharmaceuticals Corporation | $10.82 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Halley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.